跳至主要内容

Restraint Induces Sickness Responses Independent of Injection with Epstein-Barr Virus (EBV)-Encoded dUTPase

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51696#.VHVjbmfHRK0

Most adult humans have been infected by Epstein-Barr virus (EBV), a putative cause of chronic fatigue syndrome, and carry latent EBV. The EBV-encoded dUTPase can induce sickness responses in mice and chronic stress exacerbates this response. Because individuals often adapt to chronic stress, we tested the hypothesis that acute restraint stress would potentiate these sickness responses elicited by EBV-encoded dUTPase. Male CD-1 mice were injected daily for one or three days with either saline or EBV-encoded dUTPase. Additionally, mice from each condition were either restrained for three hours daily or left undisturbed during the light phase when mice are inactive. Restraint decreased weight gain during the one- and three-day experiments. Restraint in saline injected mice increased anxiety-like behavior in the open field during the three-day experiment. There were no behavioral differences during the one-day experiment. Restraint stress had no effect when experienced acutely on one day, but did produce a sickness response after three days of exposure regardless of saline or dUTPase injection. In contrast to the effects of chronic stress and EBV-encoded dUTPase on the sickness response, acute stress did not affect sickness responses in association with EBV-encoded dUTPase. Thus, dUTPase does not appear to provoke the same sickness responses after acute stress as compared to chronic stress.
Cite this paper
Aubrecht, T. , Salloum, B. , Ariza, M. , Williams, M. , Reader, B. , Glaser, R. , Sheridan, J. and Nelson, R. (2014) Restraint Induces Sickness Responses Independent of Injection with Epstein-Barr Virus (EBV)-Encoded dUTPase. Journal of Behavioral and Brain Science, 4, 491-505. doi: 10.4236/jbbs.2014.411049.

[1] Evengard, B. and Klimas, N. (2002) Chronic Fatigue Syndrome: Probable Pathogenesis and Possible Treatments. Drugs, 62, 2433-2446.
http://dx.doi.org/10.2165/00003495-200262170-00003
[2] Dantzer, R. and Kelley, K.W. (2007) Twenty Years of Research on Cytokine-Induced Sickness Behavior. Brain, Behavior, and Immunity, 21, 153-160.
http://dx.doi.org/10.1016/j.bbi.2006.09.006
[3] Glaser, R. and Kiecolt-Glaser, J.K. (2005) Stress-Induced Immune Dysfunction: Implications for Health. Nature Reviews Immunology, 5, 243-251.
http://dx.doi.org/10.1038/nri1571
[4] Dhabhar, F.S. and McEwen, B.S. (1997) Acute Stress Enhances While Chronic Stress Suppresses Cell-Mediated Immunity in Vivo: A Potential Role for Leukocyte Trafficking. Brain, Behavior, and Immunity, 11, 286-306.
http://dx.doi.org/10.1006/brbi.1997.0508
[5] Padgett, D.A. and Glaser, R. (2003) How Stress Influences the Immune Response. Trends in Immunology, 24, 444-448.
http://dx.doi.org/10.1016/S1471-4906(03)00173-X
[6] Hennessy, M.B., Deak, T. and Schiml-Webb, P.A. (2001) Stress-Induced Sickness Behaviors: An Alternative Hypothesis for Responses during Maternal Separation. Developmental Psychobiology, 39, 76-83.
http://dx.doi.org/10.1002/dev.1031
[7] Sapolsky, R.M., Romero, L.M. and Munck, A.U. (2000) How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions. Endocrine Reviews, 21, 55-89.
[8] Zhou, D., Kusnecov, A.W., Shurin, M.R., DePaoli, M. and Rabin, B.S. (1993) Exposure to Physical and Psychological Stressors Elevates Plasma Interleukin 6: Relationship to the Activation of Hypothalamic-Pituitary-Adrenal Axis. Endocrinology, 133, 2523-2530.
[9] LeMay, L.G., Vander, A.J. and Kluger, M.J. (1990) The Effects of Psychological Stress on Plasma Interleukin-6 Activity in Rats. Physiology & Behavior, 47, 957-961.
http://dx.doi.org/10.1016/0031-9384(90)90024-X
[10] Morrow, L.E., McClellan, J.L., Conn, C.A. and Kluger, M.J. (1993) Glucocorticoids alter Fever and IL-6 Responses to Psychological Stress and to Lipopolysaccharide. American Journal of Physiology, 264, R1010-R1016.
[11] Glaser, R., Litsky, M.L., Padgett, D.A., Baiocchi, R.A., Yang, E.V., Chen, M., et al. (2006) EBV-Encoded dUTPase Induces Immune Dysregulation: Implications for the Pathophysiology of EBV-Associated Disease. Virology, 346, 205-218.
http://dx.doi.org/10.1016/j.virol.2005.10.034
[12] Ariza, M.E., Glaser, R., Kaumaya, P.T., Jones, C. and Williams, M.V. (2009) The EBV-Encoded dUTPase Activates NF-κB through the TLR2 and MyD88-Dependent Signaling Pathway. Journal of Immunology, 182, 851-859.
http://dx.doi.org/10.4049/jimmunol.182.2.851
[13] Waldman, W.J., Williams Jr., M.V., Lemeshow, S., Binkley, P., Guttridge, D., Kiecolt-Glaser, J.K., et al. (2008) Epstein-Barr Virus-Encoded dUTPase Enhances Proinflammatory Cytokine Production by Macrophages in Contact with Endothelial Cells: Evidence for Depression-Induced Atherosclerotic Risk. Brain, Behavior, and Immunity, 22, 215-223.
http://dx.doi.org/10.1016/j.bbi.2007.07.007
[14] Ariza, M.E., Rivailler, P., Glaser, R., Chen, M. and Williams, M.V. (2013) Epstein-Barr Virus Encoded dUTPase Containing Exosomes Modulate Innate and Adaptive Immune Responses in Human Dendritic Cells and Peripheral Blood Mononuclear Cells. PLoS ONE, 8, e69827.
http://dx.doi.org/10.1371/journal.pone.0069827
[15] Padgett, D.A., Hotchkiss, A.K., Pyter, L.M., Nelson, R.J., Yang, E., Yeh, P.E., et al. (2004) Epstein-Barr Virus-Encoded dUTPase Modulates Immune Function and Induces Sickness Behavior in Mice. Journal of Medical Virology, 74, 442-448.
http://dx.doi.org/10.1002/jmv.20196
[16] De La Garza II, R. (2005) Endotoxin- or Pro-Inflammatory Cytokine-Induced Sickness Behavior as an Animal Model of Depression: Focus on Anhedonia. Neuroscience & Biobehavioral Reviews, 29, 761-770.
http://dx.doi.org/10.1016/j.neubiorev.2005.03.016
[17] Yirmiya, R., Pollak, Y., Morag, M., Reichenberg, A., Barak, O., Avitsur, R., et al. (2000) Illness, Cytokines, and Depression. Annals of the New York Academy of Sciences, 917, 478-487.
http://dx.doi.org/10.1111/j.1749-6632.2000.tb05412.x
[18] Aubrecht, T.G., Weil, Z.M., Ariza, M.E., Williams, M., Reader, B.F., Glaser, R., Sheridan, J.F. and Nelson, R.J. (2014) Epstein-Barr Virus (EBV)-Encoded dUTPase and Chronic Restraint Induce Impaired Learning and Memory and Sickness Responses. Physiology & Behavior, 137, 18-24.
http://dx.doi.org/10.1016/j.physbeh.2014.07.001
[19] Williams, M.V. and Pollack, J.D. (1985) Pyrimidine Deoxyribonucleotide Metabolism in Acholeplasma Laidlawii B-PG9. Journal of Bacteriology, 161, 1029-1033.
[20] Nyman, P.O. (2001) Introduction. dUTPases. Current Protein & Peptide Science, 2, 277-285.
http://dx.doi.org/10.2174/1389203013381071
[21] el-Hajj, H.H., Zhang, H. and Weiss, B. (1988) Lethality of a Dut (Deoxyuridine Triphosphatase) Mutation in Escherichia coli. Journal of Bacteriology, 170, 1069-1075.
[22] Gadsden, M.H., McIntosh, E.M., Game, J.C., Wilson, P.J. and Haynes, R.H. (1993) dUTP Pyrophosphatase Is an Essential Enzyme in Saccharomyces cerevisiae. EMBO Journal, 12, 4425-4431.
[23] Baldo, A.M. and McClure, M.A. (1999) Evolution and Horizontal Transfer of dUTPase-Encoding Genes in Viruses and Their Hosts. Journal of Virology, 73, 7710-7721.
[24] McGeoch, D.J., Cook, S., Dolan, A., Jamieson, F.E. and Telford, E.A. (1995) Molecular Phylogeny and Evolutionary Timescale for the Family of Mammalian Herpesviruses. Journal of Molecular Biology, 247, 443-458.
http://dx.doi.org/10.1006/jmbi.1995.0152
[25] Tarbouriech, N., Buisson, M., Seigneurin, J.M., Cusack, S. and Burmeister, W.P. (2005) The Monomeric dUTPase from Epstein-Barr Virus Mimics Trimeric dUTPases. Structure, 13, 1299-1310.
http://dx.doi.org/10.1016/j.str.2005.06.009
[26] Davison, A.J. and Stow, N.D. (2005) New Genes from Old: Redeployment of dUTPase by Herpesviruses. Journal of Virology, 79, 12880-12892.
http://dx.doi.org/10.1128/JVI.79.20.12880-12892.2005
[27] Camacho, A., Arrebola, R., Pena-Diaz, J., Ruiz-Perez, L.M. and Gonzalez-Pacanowska, D. (1997) Description of a Novel Eukaryotic Deoxyuridine 5'-Triphosphate Nucleotidohydrolase in Leishmania Major. Biochemical Journal, 325, 441-447.
[28] Camacho, A., Hidalgo-Zarco, F., Bernier-Villamor, V., Ruiz-Perez, L.M. and Gonzalez-Pacanowska, D. (2000) Properties of Leishmania Major dUTP Nucleotidohydrolase, a Distinct Nucleotide-Hydrolysing Enzyme in Kinetoplastids. Biochemical Journal, 346, 163-168.
http://dx.doi.org/10.1042/0264-6021:3460163
[29] Bernier-Villamor, V., Camacho, A., Hidalgo-Zarco, F., Perez, J., Ruiz-Perez, L.M. and González-Pacanowska, D. (2002) Characterization of Deoxyuridine 5’-Triphosphate Nucleotidohydrolase from Trypanosoma cruzi. FEBS Letters, 526, 147-150.
http://dx.doi.org/10.1016/S0014-5793(02)03158-7
[30] Hill, F., Loakes, D. and Brown, D.M. (1998) Polymerase Recognition of Synthetic Oligodeoxyribonucleotides Incorporating Degenerate Pyrimidine and Purine Bases. Proceedings of the National Academy of Sciences of the United States of America, 95, 4258-4263.
http://dx.doi.org/10.1073/pnas.95.8.4258
[31] Parkhill, J., Wren, B.W., Mungall, K., Ketley, J.M., Churcher, C., Basham, D., et al. (2000) The Genome Sequence of the Food-Borne Pathogen Campylobacter jejuni Reveals Hyper-variable Sequences. Nature, 403, 665-668.
http://dx.doi.org/10.1038/35001088
[32] Dantzer, R., O’Connor, J.C., Freund, G.G., Johnson, R.W. and Kelley, K.W. (2008) From Inflammation to Sickness and Depression: When the Immune System Subjugates the Brain. Nature Reviews Neuroscience, 9, 46-56.
http://dx.doi.org/10.1038/nrn2297
[33] Junker, A.K. (2005) Epstein-Barr Virus. Pediatrics in Review, 26, 79-85.
http://dx.doi.org/10.1542/pir.26-3-79
[34] Swiergiel, A.H. and Dunn, A.J. (2007) Effects of Interleukin-1β and Lipopolysaccharide on Behavior of Mice in the Elevated Plus-Maze and Open Field Tests. Pharmacology Biochemistry and Behavior, 86, 651-659.
http://dx.doi.org/10.1016/j.pbb.2007.02.010
[35] Bauer, M.E., Perks, P., Lightman, S.L. and Shanks, N. (2001) Restraint Stress Is Associated with Changes in Glucocorticoid Immunoregulation. Physiology & Behavior, 73, 525-532.
http://dx.doi.org/10.1016/S0031-9384(01)00503-0
[36] Bedrosian, T.A., Fonken, L.K., Walton, J.C., Haim, A. and Nelson, R.J. (2010) Dim Light at Night Provokes Depression-Like Behaviors and Reduces CA1 Dendritic Spine Density in Female Hamsters. Psychoneuroendocrinology, 36, 1062-1069.
http://dx.doi.org/10.1016/j.psyneuen.2011.01.004
[37] Steru, L., Chermat, R., Thierry, B. and Simon, P. (1985) The Tail Suspension Test: A New Method for Screening Antidepressants in Mice. Psychopharmacology, 85, 367-370.
http://dx.doi.org/10.1007/BF00428203
[38] Hanke, M.L., Powell, N.D., Stiner, L.M., Bailey, M.T. and Sheridan, J.F. (2012) Beta Adrenergic Blockade Decreases the Immunomodulatory Effects of Social Disruption Stress. Brain, Behavior, and Immunity, 26, 1150-1159.
http://dx.doi.org/10.1016/j.bbi.2012.07.011
[39] Mariani, T.J., Budhraja, V., Mecham, B.H., Gu, C.C., Watson, M.A. and Sadovsky, Y. (2003) A Variable Fold Change Threshold Determines Significance for Expression Microarrays. FASEB Journal, 17, 321-323.
[40] Griffin, B.E. (2000) Epstein-Barr Virus (EBV) and Human Disease: Facts, Opinions and Problems. Mutation Research, 462, 395-405.
http://dx.doi.org/10.1016/S1383-5742(00)00028-4
[41] Weinert, D. and Waterhouse, J. (1998) Diurnally Changing Effects of Locomotor Activity on Body Temperature in Laboratory Mice. Physiology & Behavior, 63, 837-843.
http://dx.doi.org/10.1016/S0031-9384(97)00546-5
[42] Mercado, A.M., Padgett, D.A., Sheridan, J.F. and Marucha, P.T. (2002) Altered Kinetics of IL-1α, IL-1β, and KGF-1 Gene Expression in Early Wounds of Restrained Mice. Brain, Behavior, and Immunity, 16, 150-162.
http://dx.doi.org/10.1006/brbi.2001.0623
[43] Munhoz, C.D., Lepsch, L.B., Kawamoto, E.M., Malta, M.B., Lima, S., et al. (2006) Chronic Unpredictable Stress Exacerbates Lipopolysaccharide-Induced Activation of Nuclear Factor-κB in the Frontal Cortex and Hippocampus via Glucocorticoid Secretion. Journal of Neuroscience, 26, 3813-3820.
http://dx.doi.org/10.1523/JNEUROSCI.4398-05.2006
[44] Gibb, J., Al-Yawer, F. and Anisman, H. (2013) Synergistic and Antagonistic Actions of Acute or Chronic Social Stressors and an Endotoxin Challenge Vary over Time Following the Challenge. Brain, Behavior, and Immunity, 28, 149-158.
http://dx.doi.org/10.1016/j.bbi.2012.11.004
[45] Johnson, J.D., O’Connor, K.A., Hansen, M.K., Watkins, L.R. and Maier, S.F. (2003) Effects of Prior Stress on LPS-Induced Cytokine and Sickness Responses. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 284, R422-R432.
[46] Bassi, G.S., Kanashiro, A., Santin, F.M., de Souza, G.E., Nobre, M.J. and Coimbra, N.C. (2012) Lipopolysaccharide-Induced Sickness Behaviour Evaluated in Different Models of Anxiety and Innate Fear in Rats. Basic & Clinical Pharmacology & Toxicology, 110, 359-369.
http://dx.doi.org/10.1111/j.1742-7843.2011.00824.x
[47] Tanaka, S., Ide, M., Shibutani, T., Ohtaki, H., Numazawa, S., Shioda, S. and Yoshida, T. (2006) Lipopolysaccharide-Induced Microglial Activation Induces Learning and Memory Deficits without Neuronal Cell Death in Rats. Journal of Neuroscience Research, 83, 557-566.
http://dx.doi.org/10.1002/jnr.20752                      eww141126lx
  
标签：

评论

发表评论

此博客中的热门博文

A Comparison of Methods Used to Determine the Oleic/Linoleic Acid Ratio in Cultivated Peanut (Arachis hypogaea L.)

Cultivated peanut ( Arachis hypogaea L.) is an important oil and food crop. It is also a cheap source of protein, a good source of essential vitamins and minerals, and a component of many food products. The fatty acid composition of peanuts has become increasingly important with the realization that oleic acid content significantly affects the development of rancidity. And oil content of peanuts significantly affects flavor and shelf-life. Early generation screening of breeding lines for high oleic acid content greatly increases the efficiency of developing new peanut varieties. The objective of this study was to compare the accuracy of methods used to classify individual peanut seed as high oleic or not high oleic. Three hundred and seventy-four (374) seeds, spanning twenty-three (23) genotypes varying in oil composition (i.e. high oleic (H) or normal/not high oleic (NH) inclusive of all four peanut market-types (runner, Spanish, Valencia and Virginia), were individually tested ...
发表评论
阅读全文

Location Optimization of a Coal Power Plant to Balance Costs against Plant’s Emission Exposure

Fuel and its delivery cost comprise the biggest expense in coal power plant operations. Delivery of electricity from generation to consumers requires investment in power lines and transmission grids. Placing a coal power plant or multiple power plants near dense population centers can lower transmission costs. If a coalmine is nearby, transportation costs can also be reduced. However, emissions from coal plants play a key role in worsening health crises in many countries. And coal upon combustion produces CO 2 , SO 2 , NO x , CO, Metallic and Particle Matter (PM10 & PM2.5). The presence of these chemical compounds in the atmosphere in close vicinity to humans, livestock, and agriculture carries detrimental health consequences. The goal of the research was to develop a methodology to minimize the public’s exposure to harmful emissions from coal power plants while maintaining minimal operational costs related to electric distribution losses and coal logistics. The objective was...
发表评论
阅读全文

Evaluation of the Safety and Efficacy of Continuous Use of a Home-Use High-Frequency Facial Treatment Appliance

At present, many home-use beauty devices are available in the market. In particular, many products developed for facial treatment use light, e.g., a flash lamp or a light-emitting diode (LED). In this study, the safety of 4 weeks’ continuous use of NEWA TM , a high-frequency facial treatment appliance, every alternate day at home was verified, and its efficacy was evaluated in Japanese individuals with healthy skin aged 30 years or older who complained of sagging of the facial skin.  Transepidermal water loss (TEWL), melanin levels, erythema levels, sebum secretion levels, skin color changes and wrinkle improvement in the facial skin were measured before the appliance began to be used (study baseline), at 2 and 4 weeks after it had begun to be used, and at 2 weeks after completion of the 4-week treatment period (6 weeks from the study baseline). In addition, data obtained by subjective evaluation by the subjects themselves on a visual analog scale (VAS) were also analyzed. Fur...
发表评论
阅读全文